To examine the effect of MED30 on tumor growth, we subcutaneously injected SNU638 cells transfected with SCR or MED30 siRNA into SCID mice, and then monitored tumor growth for seven weeks (Fig 5A). The gene discussed is MED30; the disease is neoplasm.